Taught course

Cancer Immunology and Biotechnology

Institution
University of Nottingham · School of Medicine
Qualifications
MSc

Entry requirements

2:2 degree (or international equivalent).

Months of entry

September

Course content

The biggest modern breakthrough for cancer treatment has been antibody therapies. An increasing number of biotechnology companies have antibody - or vaccine-based cancer therapies in development. This course aims to attract students interested in tumour immunology who wish to pursue a career either in industry (biotechnology) or academia.

Qualification and course duration

MSc

full time
12 months

Course contact details

Name
Postgraduate Enquiries
Email
postgraduate-enquiries@nottingham.ac.uk
Phone
+44 (0) 115 951 5559